<DOC>
	<DOCNO>NCT02525744</DOCNO>
	<brief_summary>This study evaluate new formulation LY900014 , drug lower blood sugar . It administer injection skin abdomen . The study conduct healthy people investigate quickly much LY900014 absorb effect different dos LY900014 blood sugar level . Side effect tolerability document . The study last 8 9 week participant , include screen follow . Screening require within 28 day prior enter study .</brief_summary>
	<brief_title>A Study New LY900014 Formulation Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Overtly healthy male female ( pregnant agreeable take birth control measure one month study completion ) Have body mass index ( BMI ) 18.5 30 kilogram per square meter ( kg/m^2 ) , inclusive , screen Have normal blood pressure , pulse rate , electrocardiogram ( ECG ) , blood urine laboratory test result acceptable study Are nonsmoker , smoke least 2 month prior enter study , agree smoke ( cigar , cigarette , pipe ) use smokeless tobacco duration study Are currently participate complete clinical trial within last 30 day type medical research judge incompatible study Have previously participate withdrawn study Have use health problem laboratory test result ECG reading , opinion doctor , could make unsafe participate , could interfere understand result study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>